CXCR4 inhibition in combination with anti-PD1 immunotherapy results in an effective immune response during treatment with sorafenib in hepatocellular carcinomaThomas Reiberger,Rakesh R. Ramjiawan,Yunching Chen,Mei R. Ng,Tai Hato,Elizabeth C. Unan,Tejaswini P. Reddy,Yuhui Huang,Hiroki Ochiai,Peigen Huang,Andrew X. Zhu,Rakesh K. Jain,Dan G. DudaHEPATOLOGY(2014)引用 0|浏览15暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要